Key Clinical Message:
- Immunosuppressive treatments alter the clinical manifestations of
Cutaneous Leishmaniasis
- Unconventional manifestations can cause a delay in diagnosis
- Diagnosis needs further evaluations and special consideration in
immunosuppressed patients